Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats

Neuropeptides

Volumn 34, Issue 1, 2000, Pages 38-44

  Thompson, B L ^a   Rosen, J B ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTIRELIN;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CONDITIONED REFLEX; CONTROLLED STUDY; MALE; MOTOR ACTIVITY; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALIA;

EID: 0034105426     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0785     Document Type: Article

References (35)

1. Asher R. Myxoedematus madness. BMJ. 22:1949;555-562.
2. Kirkegaard C., Faber J., Hummer L., Rogowski P. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology. 4:1979;227-235.
3. Nemeroff C. B., Evans D. L. Thyrotropin-releasing hormone (TRH), the thyroid axis, and affective disorder: a review. Ann NY Acad Sci. 553:1989;304-310.
4. Fossey M. D., Lydiard R. B., Ballenger J. C., Laraia M. T., Bissette G., Nemeroff C. B. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders. J Neuropsychiatry Clin Neurosci. 5:1993;335-337.
5. Loosen P. T., Prange A. J. Serum thyrotropin response to thryotropin releasing hormone in psychiatric patients: a review. Am J Psychiatry. 139:1982;405-416.
6. Tukel R., Kora K., Hekim N., Oguz H., Alagol F. Thyrotropin stimulating hormone response to thyrotropin releasing hormone in patients with panic disorder. Psychoneuroendocrinology. 24:1999;155-160.
7. Mineka S., Watson D., Clark L. A. Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psych. 49:1998;377-412.
8. Prange A. J. J., Wilson J. C., Lara D., Alltop L. B., Breese G. R. Effects of thyrotropin releasing hormone in depression. Lancet. 2:1972;999-1002.
9. Ehrensing R. H., Kastin A. J., Schalch D. S., Friesen H. G., Vargas J. R., Schally A. V. Affective state and thyrotropin and prolactin responses after repeated injections of thyrotropin-releasing hormone in depressed patients. Am J Psychiatry. 131:1974;714-718.
10. Coppen A., Montgomery S., Peet M., Bailey J., Marks V., Woods P. Thyrotropin-releasing hormone in the treatment of depression. Lancet. 24:1974;433-434.
11. Marangell L. B., Callahan A. M., George M. S. Effects of intrathecal thyrotropin releasing hormone (TRH) in refractory depressed patients. Arch Gen Psychiatry. 54:1997;214-222.
12. Callahan A. M., Frye M. A., Marangell L. B. Comparative antidepressant effects of parenteral and intrathecal thyrotropin releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol Psychiatry. 41:1997;264-272.
13. Drago F., Pulvirenti L., Spadara F., Pennisi G. Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats. Psychoneuroendocrinology. 15:1990;349-356.
14. Hernandez D. E., Meyer R. E., Irving P. E., Crane S. W. Reversal of pentobarbital-induced narcosis by thyrotropin-releasing hormone (TRH) in dogs. Pharmacol Res Commun. 19:1987;567-577.
15. Prange A. J. J., Breese G. R., Cott J. M. Thyrotropin releasing hormone: antagonism of pentobarbital in rodents. Life Sci. 14:1974;447-455.
16. Miyamoto M., Nagai Y., Narumi S., Saji Y., Nagawa Y. TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms. Pharmacol Biochem Behav. 17:1982;797-806.
17. Aslanov A. S., Lavretskaya G. I. Effect of TRH on the central nervous system. Neurosci Behav Physiol. 18:1987;130-134.
18. Sarkardi A., Szabo S., Laszy J., Ambrus A., Szporny L. Effects of thryrotropin-releasing hormone and its analogue L-6-ketopiperidine-2-carbonyl-leucyl-L-prolinamide on behaviour and electroencephalogram. Arzneim-Forsch Drug Res. 38:1998;1134-1138.
19. Nishino S., Arrigoni J., Shelton J., Kanbayashi T., Dement W. C., Mignot E. Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcosis. J Neurosci. 17:1997;6401-6408.
20. Kalivas P. W., Horita A. Thyrotropin-releasing hormone: neurogenesis of actions in the pentobarbital narcotized rat. J Pharmacol Exp Ther. 212:1980;203-210.
21. Charney D. S., Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol. 10:1996;419-446.
22. Rosen J. B., Schulkin J. From normal fear to pathological anxiety. Psychol Rev. 105:1998;325-350.
23. Ledoux J. E., Muller J. Emotional memory and psychopathology. Phil Trans Roy Soc Lond B. 352:1997;1719-1726.
24. Blanchard R. J., Blanchard D. C. Crouching as an index of fear. J Comp Physiol Psychol. 67:1969;370-375.
25. Davis M., Gendelman D. S., Tischler M. D., Gendelman P. M. A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci. 2:1982;791-805.
26. Lee Y., Lopez D. E., Meloni E. G., Davis M. A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci. 16:1996;3775-3789.
27. Sharif N. A. Quantitative Autoradiography of TRH receptors in discrete brain regions of different mammalian species. Ann NY Acad Sci. 553:1989;147-175.
28. Redding T. W., Schally A. V. On the half life of Thyrotropin-releasing hormone in rats. Neuroendocrinology. 9:1972;250-256.
29. Griffiths E. C. Thyrotropin releasing hormone: endocrine and central effects. Psychoneuroendocrinology. 10:1985;225-235.
30. Plappert C. F., Pilz P. K., Scnitzler H. U. Acoustic startle response and habituation in freezing and nonfreezing rats. Behav Neurosci. 107:1993;981-987.
31. Stanton T. L., Bechman A. L., Winokur A. Thyrotropin-releasing hormone effects in the central nervous system: dependence on arousal state. Science. 214:1981;678-681.
32. Davis M., Astrachan D. I. Spinal modulation of acoustic startle: opposite effects of clonidine and d-amphetamine. Psychopharmacology. 75:1981;219-225.
33. Cuthbert B. N., Bradley M. M., Lang P. J. Probing picture perception: activation and emotion. Psychophysiology. 33:1996;103-111.
34. Kalivas P. W., Stanley D., Prange A. J. J. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system. Neuropharmacology. 26:1987;33-38.
35. Mora S., Nasello A. G., Fieschi L. TRH on rat conditioned avoidance behavior: interaction with brain catecholamines. Pharmacol Biochem Behav. 13:1979;137-139.